BP Lipid 522 is a novel TCL053 analog featuring three cyclopropyl fatty acyl chains and a multichargeable methylpiperazine head group. The introduction of cyclopropane fatty acids, natural products present in bacterial membranes, is intended to assist in the next generation of lipid nanoparticle research for drug or mRNA delivery applications.
Usually ships within 24 hours.